Aspirin Reduces Bowel Cancer Risk by 63 Percent, Newcastle University Study

Two aspirin pills a day may keep the oncologist away, according to a study spanning more than a decade published today in The Lancet medical journal. Participants who took 600 milligrams of the common painkiller daily for at least two years had a 63 percent lower rate of colorectal cancer than those who took a placebo, according to the study led by John Burn, a professor of clinical genetics at Newcastle University in England. The participants all were carriers of Lynch Syndrome, a genetic condition that predisposes a person to developing certain cancers.